分子モデリングは、ドラッグデザインに利用される手法です。これは、分子の3次元構造の生成または操作および物理化学的特性を説明するのに有用です。それは分子の構造や行動の研究に役立ちます。この技術は、材料科学や計算生物学にも展開されています。生物学的特性や分子的特性を分析するために、いくつかのコンピューター化された技術が採用されています。
世界の分子モデリング市場の成長を促す要因としては、医薬品開発の増加、医薬品設計の技術的進歩、製薬会社やバイオテクノロジー企業による研究開発への投資の増加などが挙げられます。さらに、慢性疾患の有病率の上昇が市場に有利な事業機会を生み出します。一方で、分子モデリングソフトウェアの高額なコストと熟練した医療専門家の不足が市場の成長を妨げる可能性があります。
COVID-19のパンデミックは、分子モデリング市場に大きな影響を与え、分子モデリング手順となる医薬品開発プロセスの全ての段階に深刻な混乱を招きました。また、多くの医薬品開発企業や臨床研究機関（CRO）は、少なくとも一部、多くの場合全ての臨床研究を保留にすることを余儀なくされました。それにもかかわらず、スポンサーは、状況が改善すれば一時停止した研究を前進させる状態であることを確認するために、積極的な措置を講じることによってプログラムを前進させる方法を模索しています。
研究者たちは、利用可能な天然薬と合成薬の双方から今後使用可能な治療法を見つけるために、パンデミックの間にいくつかの分子分析を行いました。コンピュータシミュレーションと関連データは、以前に創薬と開発において重要な役割を示してきました。抗ウイルス薬、植物化合物、抗炎症剤などは、分子モデリング、分子動力学、ドッキングツールを使用してCOVID-19に対する試験を行った化合物の必須グループでした。その結果、さらなる実験的および臨床試験で使用されるそれらの化合物の高い有効性が確認されました。したがって、COVID-19のパンデミックにもかかわらず、分子モデリング市場の成長はプラスの影響を受けています。
目次
LIST OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF VARIOUS CHRONIC DISEASES LEADING TO DRUG DEVELOPMENT
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN DRUG DESIGN
4.2.3 INCREASING INVESTMENTS IN RESEARCH & DEVELOPMENT BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
4.3 RESTRAINTS
4.3.1 HIGH COST OF MOLECULAR MODELLING SOFTWARE
4.3.2 LACK OF SKILLED HEALTHCARE IT PROFESSIONALS IN LOW AND MIDDLE-INCOME ECONOMIES
4.4 OPPORTUNITIES
4.4.1 INTRODUCTION OF MOLECULAR MODELLING SOFTWARE AND SERVICES IN DEVELOPING ECONOMIES
?
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 INPUTS
5.1.2 SOFTWARE DEVELOPMENT PROCESSES
5.1.3 OUTPUT
5.1.4 MARKETING AND DISTRIBUTION
5.1.5 POST-SELLING SERVICES
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT
5.3.1 OVERVIEW
5.3.2 IMPACT ON MARKET GROWTH
5.3.3 IMPACT ON THE DRUG DESIGN PROCESS
5.3.4 IMPACT ON MARKET GROWTH
6 GLOBAL MOLECULAR MODELLING MARKET BY PRODUCT
6.1 INTRODUCTION
6.2 SOFTWARE
6.3 SERVICES
7 GLOBAL: MOLECULAR MODELLING MARKET BY APPLICATION
7.1 INTRODUCTION
7.2 DRUG DEVELOPMENT
7.3 DRUG DISCOVERY
7.4 OTHERS
8 GLOBAL MOLECULAR MODELLING MARKET BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3 RESEARCH & ACADEMIC CENTERS
8.4 OTHERS
?
9 GLOBAL MOLECULAR MODELLING MARKET, BY REGION
9.1 INTRODUCTION
9.2 AMERICAS
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 SOUTH AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 FRANCE
9.3.1.3 UK
9.3.1.4 ITALY
9.3.1.5 SPAIN
9.3.1.6 REST OF WESTERN EUROPE
9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST
9.5.2 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MOLECULAR MODELING MARKET
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE
GLOBAL MOLECULAR MODELING MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
10.6.2 MERGER/ACQUISITION
10.6.3 PARTNERSHIP/AGREEMENT/COLLABORATION
10.6.4 EXPANSION/INVESTMENT
11 COMPANY PROFILES
11.1 SIMULATIONS PLUS, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGY
11.2 CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGY
11.3 OPTIBRIUM
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERING
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGY
11.4 CRESSET
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERING
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGY
11.5 BIOSOLVEIT GMBH
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERING
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGY
11.6 OPENEYE SCIENTIFIC SOFTWARE
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERING
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGY
11.7 CHEMICAL COMPUTING GROUP
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERING
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGY
11.8 ACELLERA LTD
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERING
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGY
11.9 DASSAULT SYSTÈMES
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 SCHRÖDINGER, LLC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
?
11.11 CERTARA L.P.
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS/SERVICES OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 SWOT ANALYSIS
11.11.6 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
?
TABLE CONTENTS
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 4 GLOBAL: MOLECULAR MODELLING MARKET, BY SOFTWARE, BY REGION, 2017-2027 (USD MILLION)
TABLE 5 GLOBAL: MOLECULAR MODELLING MARKET, BY SERVICES, BY REGION, 2017-2027 (USD MILLION)
TABLE 6 GLOBAL: MOLECULAR MODELLING MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
TABLE 7 GLOBAL: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 8 GLOBAL: MOLECULAR MODELLING MARKET, BY DRUG DEVELOPMENT, BY REGION, 2017-2027 (USD MILLION)
TABLE 9 GLOBAL: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY, BY REGION, 2017-2027 (USD MILLION)
TABLE 10 GLOBAL: MOLECULAR MODELLING MARKET, FOR DRUG DISCOVERY, BY TYPE, 2017-2027 (USD MILLION)
TABLE 11 GLOBAL: MOLECULAR MODELLING MARKET, FOR DIRECT DRUG DESIGN, BY REGION, 2017-2027 (USD MILLION)
TABLE 12 GLOBAL: MOLECULAR MODELLING MARKET, FOR INDIRECT DRUG DESIGN, BY REGION, 2017-2027 (USD MILLION)
TABLE 13 GLOBAL: MOLECULAR MODELLING MARKET, FOR MOLECULAR MIMICRY, BY REGION, 2017-2027 (USD MILLION)
TABLE 14 GLOBAL: MOLECULAR MODELLING MARKET, BY OTHERS, BY REGION, 2017-2027 (USD MILLION)
TABLE 15 GLOBAL: MOLECULAR MODELLING MARKET, BY END USER, 2020 & 2027 (USD MILLION)
TABLE 16 GLOBAL: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 17 GLOBAL: MOLECULAR MODELLING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY REGION, 2017-2027 (USD MILLION)
TABLE 18 GLOBAL: MOLECULAR MODELLING MARKET, BY RESEARCH & ACADEMIC CENTERS, BY REGION,
2017-2027 (USD MILLION)
TABLE 19 GLOBAL: MOLECULAR MODELLING MARKET, BY OTHERS, BY REGION, 2017-2027 (USD MILLION)
TABLE 20 GLOBAL: MOLECULAR MODELLING MARKET, BY REGION 2020 & 2027 (USD MILLION)
TABLE 21 GLOBAL: MOLECULAR MODELLING MARKET, BY REGION 2017-2027 (USD MILLION)
TABLE 22 GLOBAL: MOLECULAR MODELLING MARKET SHARE, BY REGION, 2020 (%)
TABLE 23 AMERICAS: MOLECULAR MODELLING MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 24 AMERICAS: MOLECULAR MODELLING MARKET SHARE, BY REGION 2020 (%)
TABLE 25 AMERICAS: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 26 AMERICAS: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 27 AMERICAS: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 28 AMERICAS: MOLECULAR MODELLING MARKET, BY END USER , 2017-2027 (USD MILLION)
TABLE 29 NORTH AMERICA: MOLECULAR MODELLING MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 30 NORTH AMERICA: MOLECULAR MODELLING MARKET SHARE, BY COUNTRY, 2020 (%)
TABLE 31 NORTH AMERICA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 32 NORTH AMERICA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 33 NORTH AMERICA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 34 NORTH AMERICA: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 35 US: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 36 US: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 37 US: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 38 US: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 39 CANADA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 40 CANADA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 41 CANADA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 42 CANADA: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 43 SOUTH AMERICA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 44 SOUTH AMERICA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 45 SOUTH AMERICA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 46 SOUTH AMERICA: MOLECULAR MODELLING MARKET, BY END USER , 2017-2027 (USD MILLION)
TABLE 47 EUROPE: MOLECULAR MODELLING MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 48 EUROPE: MOLECULAR MODELLING MARKET SHARE, BY REGION 2020 (%)
TABLE 49 EUROPE: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 50 EUROPE: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 51 EUROPE: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 52 EUROPE: MOLECULAR MODELLING MARKET, BY END USER , 2017 - 2027 (USD MILLION)
TABLE 53 WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 54 WESTERN EUROPE: MOLECULAR MODELLING MARKET SHARE, BY COUNTRY, 2020 (%)
TABLE 55 WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 56 WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 57 WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 58 WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY END USER , 2017-2027 (USD MILLION)
TABLE 59 GERMANY: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 60 GERMANY: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 61 GERMANY: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 62 GERMANY: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 63 FRANCE: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 64 FRANCE: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 65 FRANCE: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 66 FRANCE: MOLECULAR MODELLING MARKET, BY END USER , 2017-2027 (USD MILLION)
TABLE 67 UK MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 68 UK MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 69 UK: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 70 UK: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 71 ITALY: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 72 ITALY: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 73 ITALY: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 74 ITALY: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 75 SPAIN: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 76 SPAIN: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 77 SPAIN: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 78 SPAIN: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 79 REST OF WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 80 REST OF WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 81 REST OF WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 82 REST OF WESTERN EUROPE: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 83 EASTERN EUROPE: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 84 EASTERN EUROPE: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 85 EASTERN EUROPE: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017-2027 (USD MILLION)
TABLE 86 EASTERN EUROPE: MOLECULAR MODELLING MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 87 ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 88 ASIA-PACIFIC: MOLECULAR MODELLING MARKET SHARE, BY COUNTRY 2020 (%)
TABLE 89 ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 90 ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 91 ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 92 ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 93 CHINA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 94 CHINA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 95 CHINA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 96 CHINA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 97 INDIA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 98 INDIA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 99 INDIA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 100 INDIA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 101 JAPAN: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 102 JAPAN: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 103 JAPAN: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 104 JAPAN: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 105 AUSTRALIA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 106 AUSTRALIA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 107 AUSTRALIA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 108 AUSTRALIA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 109 SOUTH KOREA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 110 SOUTH KOREA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 111 SOUTH KOREA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 112 SOUTH KOREA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 116 REST OF ASIA-PACIFIC: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET SHARE, BY COUNTRY 2020 (%)
TABLE 119 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 123 MIDDLE EAST: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 124 MIDDLE EAST: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 125 MIDDLE EAST: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 126 MIDDLE EAST: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 127 AFRICA: MOLECULAR MODELLING MARKET, BY PRODUCT, 2017 - 2027 (USD MILLION)
TABLE 128 AFRICA: MOLECULAR MODELLING MARKET, BY APPLICATION, 2017 - 2027 (USD MILLION)
TABLE 129 AFRICA: MOLECULAR MODELLING MARKET, BY DRUG DISCOVERY TYPE, 2017 - 2027 (USD MILLION)
TABLE 130 AFRICA: MOLECULAR MODELLING MARKET, BY END USER, 2017 - 2027 (USD MILLION)
TABLE 131 MAJOR MANUFACTURERS IN THE GLOBAL MOLECULAR MODELING MARKET
TABLE 132 MOST ACTIVE PLAYER IN THE GLOBAL MOLECULAR MODELING MARKET
TABLE 133 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 134 MERGER/ACQUISITION
TABLE 135 PARTNERSHIP/AGREEMENT/COLLABORATION
TABLE 136 EXPANSION/INVESTMENT
TABLE 137 SIMULATIONS PLUS, INC.: PRODUCTS/SERVICES OFFERED
TABLE 138 SIMULATIONS PLUS, INC.: KEY DEVELOPMENTS
TABLE 139 SIMULATIONS PLUS, INC.: PRODUCTS/SERVICES OFFERING
TABLE 140 SIMULATIONS PLUS, INC.: KEY DEVELOPMENTS
TABLE 141 OPTIBRIUM: PRODUCTS/SERVICES OFFERING
TABLE 142 OPTIBRIUM: KEY DEVELOPMENTS
TABLE 143 CRESSET: PRODUCTS/SERVICES OFFERING
TABLE 144 CRESSET: KEY DEVELOPMENTS
TABLE 145 BIOSOLVEIT GMBH: PRODUCTS/SERVICES OFFERING
TABLE 146 BIOSOLVEIT GMBH: KEY DEVELOPMENTS OFFERING
TABLE 147 OPENEYE SCIENTIFIC SOFTWARE: PRODUCTS/SERVICES OFFERING
TABLE 148 OPENEYE SCIENTIFIC SOFTWARE: KEY DEVELOPMENTS OFFERING
TABLE 149 CHEMICAL COMPUTING GROUP: PRODUCTS/SERVICES OFFERING
TABLE 150 ACELLERA LTD: PRODUCTS/SERVICES OFFERING
TABLE 151 ACELLERA LTD: KEY DEVELOPMENTS
TABLE 152 DASSAULT SYSTEMES: PRODUCTS/SERVICES OFFERED
TABLE 153 SCHRÖDINGER, LLC: PRODUCTS/SERVICES OFFERED
TABLE 154 CERTARA LP: PRODUCTS/SERVICES OFFERED
?
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MOLECULAR MODELLING MARKET STRUCTURE
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: MOLECULAR MODELLING MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: MOLECULAR MODELING MARKET
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: MOLECULAR MODELING MARKET
FIGURE 9 GLOBAL MOLECULAR MODELLING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION)
FIGURE 10 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 11 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MOLECULAR MODELING MARKET
FIGURE 12 GLOBAL MOLECULAR MODELLING MARKET: COMPETITIVE LANDSCAPE
FIGURE 13 SIMULATIONS PLUS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 SIMULATIONS PLUS, INC.: SWOT ANALYSIS
FIGURE 15 CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE: SWOT ANALYSIS
FIGURE 16 OPTIBRIUM: SWOT ANALYSIS
FIGURE 17 CRESSET: SWOT ANALYSIS
FIGURE 18 BIOSOLVEIT GMBH: SWOT ANALYSIS
FIGURE 19 OPENEYE SCIENTIFIC SOFTWARE: SWOT ANALYSIS
FIGURE 20 CHEMICAL COMPUTING GROUP: SWOT ANALYSIS
FIGURE 21 ACELLERA LTD: SWOT ANALYSIS
FIGURE 22 DASSAULT SYSTÈMES: SWOT ANALYSIS
FIGURE 23 DASSAULT SYSTEMES: SWOT ANALYSIS
FIGURE 24 SCHRÖDINGER, LLC: SWOT ANALYSIS
FIGURE 25 CERTARA LP: SWOT ANALYSIS
